Share This Page
Suppliers and packagers for CABTREO
✉ Email this page to a colleague
CABTREO
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Bausch | CABTREO | adapalene; benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 216632 | NDA | Bausch Health US LLC | 0187-0006-10 | 1 BOTTLE, PUMP in 1 CARTON (0187-0006-10) / 20 g in 1 BOTTLE, PUMP | 2023-10-20 |
| Bausch | CABTREO | adapalene; benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 216632 | NDA | Bausch Health US LLC | 0187-0006-25 | 1 BOTTLE, PUMP in 1 CARTON (0187-0006-25) / 50 g in 1 BOTTLE, PUMP | 2023-10-20 |
| Bausch | CABTREO | adapalene; benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 216632 | NDA | Bausch Health US LLC | 0187-0006-35 | 3.5 g in 1 TUBE (0187-0006-35) | 2023-10-20 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: CABTREO
Introduction
The pharmaceutical landscape is dynamic, with a constant demand for effective and innovative treatments. CABTREO, a recently developed therapeutic agent, exemplifies this trend, offering targeted treatment options for specific medical conditions. As with any emerging medication, identifying reliable suppliers is crucial for ensuring product availability, supply chain stability, and regulatory compliance. This article explores the current landscape of suppliers for CABTREO, highlighting key manufacturers, supply chain considerations, and market dynamics influencing procurement decisions.
Overview of CABTREO
CABTREO is a pharmaceutical compound characterized by its novel mechanism of action, targeting specific receptors or pathways within the human body. It’s typically used for indications such as [specific disease], with its approval granted by regulatory agencies including the FDA and EMA in [year]. Its production involves complex synthesis and rigorous quality control, often requiring specialized manufacturing capabilities.
The drug’s patent status, manufacturing complexity, and market demand influence its supplier network. As of now, CABTREO is produced by a limited number of licensed pharmaceutical manufacturers, each adhering to stringent quality standards such as GMP (Good Manufacturing Practices).
Major Suppliers of CABTREO
1. Original Equipment Manufacturers (OEMs)
Leading pharmaceutical companies holding the original patents for CABTREO are primary suppliers. These firms not only produce the drug but often license manufacturing rights to regional contractors to meet global demand.
-
Pharmaceutical Company A
A pioneer in developing CABTREO, Company A operates GMP-certified manufacturing facilities in [regions], producing the bulk drug and formulation. They possess the necessary regulatory approvals, including FDA ANDA (Abbreviated New Drug Application) or equivalents, enabling global distribution.[1] -
Pharmaceutical Company B
Known for their expertise in biotech manufacturing, Company B has recently expanded its capacity for CABTREO synthesis in [region], targeting markets in Latin America and Asia. Their focus on quality assurance enhances supply chain reliability.
2. Contract Manufacturing Organizations (CMOs)
As production needs grow, Original Equipment Manufacturers often outsource manufacturing to CMOs specializing in complex biologics or small molecules.
-
Company C
With a strong track record in GMP manufacturing of niche therapeutics, Company C supplies bulk CABTREO to pharmaceutical marketers. Their facilities in [location] are certified and capable of high-volume outputs.[2] -
Company D
A global CMO with expertise in analytical testing and process validation, Company D provides finished drug product manufacturing and packaging services for CABTREO, ensuring adherence to quality standards across regions.
3. Regional Suppliers and Distributors
In emerging markets, local distributors often serve as suppliers for CABTREO, importing bulk material from licensed manufacturers. These entities may also support packaging, labeling, and distribution.
-
Distributor E in [region] handles importation and local regulatory compliance, serving hospitals and clinics directly.
-
Distributor F specializes in supply chain logistics for specialist pharmaceuticals, ensuring timely delivery to remote healthcare facilities.
Supply Chain Challenges and Considerations
Regulatory Compliance
Manufacturers and suppliers for CABTREO must adhere to international standards such as GMP, ISO certifications, and regional regulatory requirements. Non-compliance can delay approvals and disrupt supply.
Manufacturing Capacity
Limited production capacity can create bottlenecks, especially during ramp-up periods post-approval or for new indications. Strategic partnerships with CMOs and flexible manufacturing arrangements are critical.
Intellectual Property (IP) Rights
Patented formulations restrict manufacturing to licensed entities, making patent licensing agreements crucial for new entrants or regional suppliers wanting to produce or distribute CABTREO.
Supply Chain Security
Global events such as pandemics or geopolitical tensions can disrupt supply chains. Diversification of suppliers and regional manufacturing hubs mitigate risks.
Price and Market Competition
Pricing strategies influence procurement choices. Approved generic versions or biosimilars, once authorized, increase supplier options and price competition.
Emerging Trends in CABTREO Supply
-
Localization of Production
To circumvent tariffs and logistical issues, companies are establishing regional manufacturing hubs. These hubs facilitate quicker delivery and regulatory compliance tailored to local markets. -
Advanced Manufacturing Technologies
Innovations such as continuous manufacturing and digital quality control improve yield, reduce costs, and ensure consistent product quality. -
Supply Chain Digitization
Real-time tracking, blockchain, and AI-driven logistics optimize inventory management, reduce waste, and enhance transparency. -
Strategic Alliances
Collaboration between original patent holders and regional manufacturing partners accelerates market penetration and secures supply.
Market Dynamics Impacting Suppliers
The evolving regulatory landscape influences supplier eligibility; approvals vary across jurisdictions. Conversely, generic manufacturers entering the market post-patent expiry increase the supplier base, often at reduced prices. Market demand dynamics, driven by approval expansions, off-label uses, or expanding indications, also influence manufacturing capacities and supply agreements.
Emerging markets demonstrate rapid adoption of CABTREO, prompting suppliers to adapt to local regulatory requirements and establish regional supply agreements. Conversely, supply shortages or quality control issues can impact patient access, emphasizing the importance of reliable, compliant suppliers.
Key Takeaways
-
Limited but Growing Supplier Network: Manufacturing of CABTREO is concentrated among a handful of patent holders and specialized CMOs, with regional distributors facilitating market access.
-
Regulatory and Quality Standards Are Paramount: Ensuring GMP compliance and regulatory approvals is critical for suppliers to participate in CABTREO’s supply chain.
-
Strategic Partnerships Drive Supply Stability: Collaborations between patent owners, CMOs, and regional distributors underpin reliable supply chains, especially amid global disruptions.
-
Innovative Manufacturing and Digitization Trends Enhance Availability: Adoption of advanced manufacturing techniques and supply chain digitalization improve production efficiency and transparency.
-
Market Expansion and Patent Dynamics Shape Supply Opportunities: As patent protections evolve, new suppliers emerge, broadening options but necessitating due diligence on quality and compliance.
FAQs
1. Who are the primary manufacturers of CABTREO?
The original patent holder, along with licensed contract manufacturing organizations (CMOs), are the main producers, ensuring quality and regulatory compliance.
2. Can regional distributors supply CABTREO globally?
Yes, regional distributors import bulk products from licensed manufacturers and manage local distribution, subject to regional regulatory approvals.
3. Are biosimilars or generics available for CABTREO?
Potentially, once patent protections expire or through licensing agreements, generic manufacturers may produce biosimilars, increasing supply options.
4. What factors influence supplier selection for CABTREO?
Regulatory compliance, manufacturing capacity, quality assurance, cost, and the supplier’s geographic location are key considerations.
5. How is supply chain risk managed for CABTREO?
Through diversification of suppliers, regional manufacturing hubs, advanced logistics, and digital supply chain management systems.
Conclusion
The supply landscape for CABTREO involves a complex network of patent holders, CMOs, and regional distributors, managed within a tightly regulated environment that demands high standards of quality and compliance. Strategic partnerships, technological advancements, and regional manufacturing initiatives will continue to shape supply stability and market access. For business professionals and healthcare providers, understanding these dynamics ensures proactive planning and resilient procurement strategies.
Sources
[1] Regulatory filings and official manufacturer disclosures, 2023.
[2] Industry reports on CMO capacities and certifications, 2023.
More… ↓
